Gilks CB - Search Results

1

Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification.

Kim SR, Cloutier BT, Leung S, Cochrane D, Britton H, Pina A, Storness-Bliss C, Farnell D, Huang L, Shum K, Lum A, Senz J, Lee CH, Gilks CB, Hoang L, McAlpine JN. Kim SR, et al. Among authors: gilks cb. Gynecol Oncol. 2020 Jul;158(1):3-11. doi: 10.1016/j.ygyno.2020.04.043. Epub 2020 Apr 21. Gynecol Oncol. 2020. PMID: 32331700

2

Recurrent endometrial adenocarcinoma: presentation as a splenic mass mimicking malignant lymphoma.

Gilks CB, Acker BD, Clement PB. Gilks CB, et al. Gynecol Oncol. 1989 May;33(2):209-11. doi: 10.1016/0090-8258(89)90554-4. Gynecol Oncol. 1989. PMID: 2649423 Review.

3

Small-cell carcinoma of the endometrium. A clinicopathological study of sixteen cases.

Huntsman DG, Clement PB, Gilks CB, Scully RE. Huntsman DG, et al. Among authors: gilks cb. Am J Surg Pathol. 1994 Apr;18(4):364-75. doi: 10.1097/00000478-199404000-00005. Am J Surg Pathol. 1994. PMID: 7511354 Review.

4

Low-risk endometrial carcinoma: assessment of a treatment policy based on tumor ploidy and identification of additional prognostic indicators.

Lim P, Aquino-Parsons CF, Wong F, Dupuis B, Phillips D, Zhou C, Gilks CB. Lim P, et al. Among authors: gilks cb. Gynecol Oncol. 1999 May;73(2):191-5. doi: 10.1006/gyno.1999.5365. Gynecol Oncol. 1999. PMID: 10329033

5

Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases.

Al-Ghamdi A, Freedman D, Miller D, Poh C, Rosin M, Zhang L, Gilks CB. Al-Ghamdi A, et al. Among authors: gilks cb. Gynecol Oncol. 2002 Jan;84(1):94-101. doi: 10.1006/gyno.2001.6466. Gynecol Oncol. 2002. PMID: 11748983

6

Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.

Al Kushi A, Lim P, Aquino-Parsons C, Gilks CB. Al Kushi A, et al. Among authors: gilks cb. Mod Pathol. 2002 Apr;15(4):365-71. doi: 10.1038/modpathol.3880531. Mod Pathol. 2002. PMID: 11950909

7

Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level.

Alkushi A, Lim P, Coldman A, Huntsman D, Miller D, Gilks CB. Alkushi A, et al. Among authors: gilks cb. Int J Gynecol Pathol. 2004 Apr;23(2):129-37. doi: 10.1097/00004347-200404000-00007. Int J Gynecol Pathol. 2004. PMID: 15084841

8

Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts.

Woo MM, Gilks CB, Verhage HG, Longacre TA, Leung PC, Auersperg N. Woo MM, et al. Among authors: gilks cb. Gynecol Oncol. 2004 May;93(2):315-9. doi: 10.1016/j.ygyno.2004.01.047. Gynecol Oncol. 2004. PMID: 15099939

9

Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models.

Lee CH, Xue H, Sutcliffe M, Gout PW, Huntsman DG, Miller DM, Gilks CB, Wang YZ. Lee CH, et al. Among authors: gilks cb. Gynecol Oncol. 2005 Jan;96(1):48-55. doi: 10.1016/j.ygyno.2004.09.025. Gynecol Oncol. 2005. PMID: 15589579

10

Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling.

Gilks CB, Vanderhyden BC, Zhu S, van de Rijn M, Longacre TA. Gilks CB, et al. Gynecol Oncol. 2005 Mar;96(3):684-94. doi: 10.1016/j.ygyno.2004.11.039. Gynecol Oncol. 2005. PMID: 15721412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters